Global Spinal Devices and Biologics Market to Grow 6.9% Annually

The global spinal device and biologics market is expected to grow at a compound annual growth rate of 6.9 percent until 2015, according to the latest analysis by Reporterlink.

Advertisement

One of the key factors contributing to this market growth is the development of better and longer-lasting implants. The market has also been witnessing an increase in the number of strategic alliances. However, the shortage of healthcare workers and high wages could pose a challenge to the growth of this market.

Companies dominating this market include DePuy, Medtronic, Stryker and Synthes.

More Articles on Devices:

Spinal Elements Launches Ti-Bond

Exactech Announces 2Q Revenue of $55.2M, Up 7%

DJO Global 2Q Net Sales Reach $286M, a 2.9% Increase

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.